STOCK TITAN

MakeMyTrip CEO Rajesh Magow sells 20,000 and 10,000 shares

Reported sale-price ranges were $45.20 to $45.45 on November 3 and $50.01 to $50.37 on November 4.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

MakeMyTrip Ltd's Group Chief Executive Officer Rajesh Magow converted 20,000 Restricted Stock Units (RSUs) into ordinary shares at $0.0005 per share on November 3, 2026, and sold 20,000 shares at a weighted average of $45.25 per share. On November 4, he converted 10,000 RSUs into ordinary shares at $0.0005 per share and sold 10,000 shares at a weighted average of $50.11 per share. No Rule 10b5-1 plan is reported. Following November 4, 1,374,185 RSUs were vested and 29,478 were unvested, including 14,739 subject to performance-based vesting conditions.

Insider Magow Rajesh
Role Group Chief Executive Officer
Sold 30,000 shs ($1.41M)
Approx. gross sale proceeds $1.41M
Approx. exercise cost $15.00
Approx. pre-tax spread $1.41M
Share of Position Sold 100%
Type Security Shares Price Value
Exercise Restricted Stock Units F4 10,000 $0.00 $0.00
Exercise Ordinary Shares 10,000 $0.0005 $5.00
Sale Ordinary Shares F2 10,000 $50.11 $501K
Exercise Restricted Stock Units F3 20,000 $0.00 $0.00
Exercise Ordinary Shares 20,000 $0.0005 $10.00
Sale Ordinary Shares F1 20,000 $45.25 $905K
Holdings After Transaction: Restricted Stock Units — 1,403,663 contracts (Direct); Ordinary Shares — 0 shares (Direct)
Holdings Before and After: Restricted Stock Units, 1,433,663 to 1,403,663 contracts (Direct); Ordinary Shares, 0 to 0 shares (Direct)
Footnotes (4)
  1. F1. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
  2. F2. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
  3. F3. Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions.
  4. F4. Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.
RSUs converted on November 3 20,000 RSUs Converted into ordinary shares on November 3, 2026
Conversion price $0.0005 per share RSU conversions on November 3 and November 4, 2026
Shares sold on November 3 20,000 ordinary shares November 3, 2026
Weighted average sale price $45.25 per share November 3, 2026
Shares sold on November 4 10,000 ordinary shares November 4, 2026
Weighted average sale price $50.11 per share November 4, 2026
Vested RSUs 1,374,185 RSUs Following the transaction dated November 4, 2026
Unvested RSUs 29,478 RSUs Following the transaction dated November 4, 2026
Restricted Stock Units financial
"converted 20,000 Restricted Stock Units (RSUs)"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
performance-based RSUs financial
"include 14,739 performance-based RSUs"
Performance-based restricted stock units (RSUs) are promises to deliver company shares to employees only if the business meets specific goals, such as revenue, profit, stock-price targets, or strategic milestones. For investors, they matter because they change future share supply and align management incentives with company results—like a salesperson whose bonus only pays out when sales targets are hit—so they can affect earnings, dilution, and confidence in leadership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MMYT shares did Rajesh Magow sell, and at what prices?

Rajesh Magow sold 20,000 ordinary shares on November 3, 2026, at a weighted average of $45.25 per share, and 10,000 on November 4 at a weighted average of $50.11 per share. The reported sale-price ranges were $45.20 to $45.45 and $50.01 to $50.37, respectively. No Rule 10b5-1 plan is reported.

When were Rajesh Magow's unvested RSUs scheduled to vest?

The 29,478 unvested RSUs were scheduled to vest between April 1, 2027, and April 1, 2030. Their expiration dates ranged from March 31, 2031, to March 31, 2034, subject to extension at MakeMyTrip Ltd's sole discretion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Magow Rajesh

(Last)(First)(Middle)
CM 717 B, THE CAMELLIAS
DLF PHASE V GOLF LINKS,

(Street)
GURGAON122009

(City)(State)(Zip)

INDIA

(Country)
2. Issuer Name and Ticker or Trading Symbol
MakeMyTrip Ltd [ MMYT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Group Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/03/2026M20,000A$0.000520,000D
Ordinary Shares11/03/2026S20,000D$45.25(1)0D
Ordinary Shares11/04/2026M10,000A$0.000510,000D
Ordinary Shares11/04/2026S10,000D$50.11(2)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0.000511/03/2026M20,000 (3) (3)Ordinary Shares20,000$01,413,663D
Restricted Stock Units$0.000511/04/2026M10,000 (4) (4)Ordinary Shares10,000$01,403,663D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
2. The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
3. Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions.
4. Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.
/s/ Rajesh Magow11/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading